Managing Multiple Sclerosis: Current Treatment and Care Management Strategies for Managed Care
Jointly provided by
Impact Education, LLC    
This activity is supported by independent educational grants from Celgene Corporation and Sanofi Genzyme.

You Are Invited to a LIVE Free CME/CNE/CPE Webcast:
Managing Multiple Sclerosis: Current Treatment and Care Management Strategies for Managed Care Live Webcast

Live Webcast Date

Tuesday August 21, 2018 12:30 PM - 2:00 PM ET

  • Review of recently approved and emerging therapies
  • Quality standards, health care policy, and benefit designs to enhance outcomes
  • Care pathways to manage and improve economic outcomes
  • Health coaching strategies to enhance patient engagement
James Kenney, Jr., RPh, MBA
Manager, Specialty and Pharmacy Contracts
Harvard Pilgrim Health Care
Edmund Pezalla, MD, MPH
Enlightenment Bioconsult, LLC
Harold Moses, Jr., MD
Associate Professor of Neurology
Neuroimmunology Division
Vanderbilt University
Kyle Pinion
Senior Director of Education, Healthcare Relations & Advocacy
Multiple Sclerosis Association of America
  • Managed care pharmacy directors, clinical pharmacists, quality directors, medical directors
  • Pharmacy directors, specialty pharmacists, quality directors, care managers, registered nurses, and other managed care and payer organization professionals

Multiple sclerosis (MS) is a complex disease that requires a collaborative approach to care to achieve optimal patient care and outcomes. Disease-modifying therapies (DMTs) are a core component of MS management. Due to a lack of head-to-head trials it is difficult to determine which therapy would be most effective for MS; however, it is possible to evaluate current therapies based on their effects on sustained disability, relapse rate, lesion load, brain atrophy, and cognitive dysfunction. Members of the clinical team, as well as patients, need to coordinate these efforts when choosing the appropriate therapy and continually monitor the disease while managing symptoms and the psychological aspects of the disease. Therefore, it is important for specialty pharmacists and other managed care professionals to be aware of and engaged in the care and treatment of patients with MS.

The activity will consist of four expert faculty demonstrating the unique value each brings to the overall care of patients through real world examples and case studies. By working together via data sharing and collaboration between payers, clinicians, specialty pharmacy, and patients, on a more integrated approach, current barriers will be overcome, demonstrating value to all parties and motivating them to become further engaged.


After completing the activity, participants should be better able to:
  • Review recent insights into the safety, efficacy, and attributes of emerging MS therapies
  • Apply managed care MS treatment algorithms with recent clinical trial data
  • Analyze care pathways and their application to manage economic outcomes in MS
  • Employ health coaching strategies to enhance MS patient engagement in their care
Opening Comments/Overview
James Kenney, Jr., RPh, MBA
Clinical Update: Current Insights into MS Treatment
Harold Moses, Jr., MD
MS Care Pathways and Algorithms to Improve Clinical and Economic Outcomes
Edmund Pezalla, MD, MPH
Health Coaching Strategies for Optimal MS Management
James Kenney, Jr., RPh, MBA
Patient Perspective - MSAA Overview
Kyle Pinion
Audience Question and Answer Session

Key Takeaways and Closing Comments
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - JA4008162-9999-18-080-L01-P
Type of Activity: Application

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up.

Fee Information
There is no fee for this educational activity.

Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.

If you have any questions, please call (215) 619-8812 or email